Lv11
70 积分 2021-06-24 加入
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis
1个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
1个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
1个月前
已完结
Tegileridine: First Approval
1个月前
已完结
The Drug-Dosing Conundrum in Oncology — When Less Is More
2个月前
已完结
CD38 — a new target in renal immune disease
2个月前
已完结
The potential of CD38 protein as a target for autoimmune diseases
2个月前
已完结
New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review
3个月前
已完结
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
4个月前
已完结
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
4个月前
已完结
皖公网安备34019202002308
